PPD, Inc. purchased stocks and warrants worth $3.6 million in BioDelivery Sciences International on Tuesday.

PPD (Nasdaq: PPDI) says it is interested in BioDelivery’s patented technology for possible oral delivery of drugs vs. injection. The investment was made as part of BioDelivery’s recently concluded public offering.

PPD: www.ppdi.com